Galt stock

norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... May 02, 2022 · Galectin Therapeutics' stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GALT stock has decreased by 21.1% and is now trading at $1.57. View which stocks have been most impacted by COVID-19. Galectin Therapeutics Inc. advanced stock charts by MarketWatch. View GALT historial stock data and compare to other stocks and exchanges.Galectin Therapeutics Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Streamlining Its Capital Structure GlobeNewswire Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases.Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.GALECTIN THERAPEUTICS stock was originally listed at a price of $12.00 in Sep 9, 2002. If you had invested in GALECTIN THERAPEUTICS stock at $12.00, your return over the last 19 years would have been -86%, for an annualized return of -9.83% (not including any dividends or dividend reinvestments).A.L.I. is an ISO 9001-certified label manufacturer specializing in product and packaging labels for many industries, especially the automotive OEM and after market parts industries. We have the capacity to print up to seven colors, including 4-color process, and employ a full service Art & Design Department utilizing state-of-the-art computers ... The latest messages and market ideas from Galectin Therapeutics (@GalectinTherapeutics) on Stocktwits. Galectin Therapeutics Inc. (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share Simply Wall St • Nov 17, 2021 How Much Of Galectin...Find the latest Galectin Therapeutics Inc., GALT stock market data. Get a full understanding of how Galectin Therapeutics Inc. is performing with stock quotes and prices, as well as real-time news ...No significant news for GALT in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.52 Market Cap $92.00 M Shares Outstanding 59.36 M Public Float 42.57 M Yield GALT is not...norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... Company Name: Galectin Therapeutics Inc., Stock Symbol: GALT, Industry: Biotechs, Total Posts: 3747, Last Post: 2/1/2022 3:50:12 PMGalectin Therapeutics Inc.'s (NASDAQ:GALT) value has fallen 11% in the last week, but insiders who sold US$130k worth of stock over the last year have had less success. Insiders might have been...Galectin Therapeutic (GALT) $2.07 0.05 (2.36%) 16:00 EST GALT Stock Quote Delayed 30 Minutes.Galectin Therapeutics Inc. is a biotechnology company that is focused on developing novel therapies to improve the lives of patients with chronic liver disease and cancer. The Company's product candidates include galectin-3 inhibitor, belapectin (GR-MD-02) and GM-CT-01.Ticker: GALT. Galectin Therapeutics Inc is a incorporated in the state of Nevada. Galectin Therapeutics Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current ...The Galectin Therapeutics Inc. stock price fell by -1.19% on the last day (Friday, 22nd Apr 2022) from $1.68 to $1.66. and has now fallen 3 days in a row. During the day the stock fluctuated 6.17% from a day low at $1.62 to a day high of $1.72.Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.GALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization... GALT | Complete Galectin Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.SEC Filings. Analyst Coverage. Corporate Governance. Shareholder Services. Corporate Presentation. Contact. Developing novel therapeutics. for metabolic and endocrine disorders. Developing novel therapeutics. Mr. Lewis and Galectin Therapeutics Inc. entered into an employment agreement, dated August 31, 2020, and a Deferred Stock Unit Agreement, dated August 31, 2020. Pursuant to these agreements, 80% of Mr. Lewis' compensation will be paid in the form of deferred stock units ("DSUs") in accordance with the terms and subject to the provisions set ...Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share Simply Wall St • Nov 17, 2021 How Much Of Galectin...Implied Volatility Surging for Galectin Therapeutics (GALT) Stock Options 09/29/20-7:52AM EST Zacks New Strong Sell Stocks for August 31st 08/31/20-10:10AM EST ZacksGALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization... Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-Industry N/A Sector Medical Current Symbol NASDAQ:GALT Previous Symbol CUSIP N/A CIK 1133416 Web www.galectintherapeutics.com Phone (678) 620-3186 Fax 770-864-1327 Employees 6 Year Founded N/A Sales & Book Value Annual Sales N/A Price / Sales N/A Cash Flow N/A Price / Cash Flow N/AGalectin Therapeutics Inc. (NASDAQ:GALT) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for GALT is 23.5 ...Closing yesterday's session at $2.59, the stock is trading 54.6% below its all-time high. Also, the stock has declined 26% over the past month and 6.8% over the past year. GALT is currently trading lower than its $3.65 and $2.82 respective 50-day and 200-day moving averages, which indicates a downtrend.Find real-time GALT - Galectin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... A Form 4 filing filed with the SEC on Tuesday, January 19 showed that Amelio Gilbert F sold 60,000 shares of Galectin Therapeutics Inc (NASDAQ: GALT )at an average price of $2.17.Galectin Therapeutics Inc. is a biotechnology company that is focused on developing therapies to improve the lives of patients with fibrotic disease, chronic liver disease and cancer. The Company’s product candidates include galectin-3 inhibitor, which is a belapectin (GR-MD-02) and GM-CT-01. The Company’s lead drug belapectin is ...Auction Market 12495 East Stockton Blvd. | Galt, CA 95632 Phone: 209-745-1515 | Fax: 209-745-1582 Email: [email protected] 27, 2018 · Shares of the clinical-stage biotech Galectin Therapeutics ( GALT 0.59% ) are ripping higher today after the company announced a new patent covering the use of GR-MD-02 as a means to treat ... To see how Galectin Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: GALT stock's performance was 10.13% in the latest trading, and -20.55% in the past year, while Savara Inc. (SVRA) has traded -2.33% on the day and positioned -28.00% lower than it was a year ago.The latest messages and market ideas from Galectin Therapeutics (@GalectinTherapeutics) on Stocktwits. Galectin Therapeutics Inc. (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.The Galectin Therapeutics Inc. stock price fell by -1.19% on the last day (Friday, 22nd Apr 2022) from $1.68 to $1.66. and has now fallen 3 days in a row. During the day the stock fluctuated 6.17% from a day low at $1.62 to a day high of $1.72.A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.To access the latest ESG Research, Visit the new Stock Dashboard Full Time Employees: 9 Executives galectintherapeutics.com 4960 Peachtree Industrial Boulevard, Suite 240 Norcross, GA 30071 United States of America 1-678 620 3186 Analyst Opinions Equity Summary Score -active tab All OpinionsGALT Galectin Therapeutics Inc Current Report Filing (8-k) On March 31, 2022, Galectin Therapeutics Inc. ("Galectin Therapeutics") issued a press release announcing its results of operations and financial condition as of and for the year ended December 31, 2021 and provided a business update.May 01, 2015 · Latest Transactions. View All. USD 15 000 000 6.75%, 2-Year Public Placement. 28 Jan 2022. USD 12 000 000 6.50%, 3-Year Public Placement. 17 Dec 2021. Galectin Therapeutics Inc.'s (NASDAQ:GALT) value has fallen 11% in the last week, but insiders who sold US$130k worth of stock over the last year have had less success. Insiders might have been...Galectin Therapeutics Inc. is a biotechnology company that is focused on developing novel therapies to improve the lives of patients with chronic liver disease and cancer. The Company's product candidates include galectin-3 inhibitor, belapectin (GR-MD-02) and GM-CT-01.Galectin Therapeutics Inc. is a biotechnology company that is focused on developing novel therapies to improve the lives of patients with chronic liver disease and cancer. The Company's product candidates include galectin-3 inhibitor, belapectin (GR-MD-02) and GM-CT-01.In depth view into GALT (Galectin Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.GALT : 1.5700 (+1.29%) Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein Globe Newswire - Tue Dec 21, 2021. NORCROSS, Ga., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-Industry N/A Sector Medical Current Symbol NASDAQ:GALT Previous Symbol CUSIP N/A CIK 1133416 Web www.galectintherapeutics.com Phone (678) 620-3186 Fax 770-864-1327 Employees 6 Year Founded N/A Sales & Book Value Annual Sales N/A Price / Sales N/A Cash Flow N/A Price / Cash Flow N/AGet the latest news and real-time alerts from Galectin Therapeutics Inc. (GALT) stock at Seeking Alpha.A.L.I. is an ISO 9001-certified label manufacturer specializing in product and packaging labels for many industries, especially the automotive OEM and after market parts industries. We have the capacity to print up to seven colors, including 4-color process, and employ a full service Art & Design Department utilizing state-of-the-art computers ... The Galectin Therapeutics Inc. stock price fell by -1.19% on the last day (Friday, 22nd Apr 2022) from $1.68 to $1.66. and has now fallen 3 days in a row. During the day the stock fluctuated 6.17% from a day low at $1.62 to a day high of $1.72.Galectin Therapeutics Inc. (NASDAQ:GALT) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for GALT is 23.5 ...Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share Simply Wall St • Nov 17, 2021 How Much Of Galectin...A.L.I. is an ISO 9001-certified label manufacturer specializing in product and packaging labels for many industries, especially the automotive OEM and after market parts industries. We have the capacity to print up to seven colors, including 4-color process, and employ a full service Art & Design Department utilizing state-of-the-art computers ... Galectin Therapeutics (GALT) has 2 splits in our GALT split history database. The first split for GALT took place on September 20, 1999. This was a 2 for 1 split, meaning for each share of GALT owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.GALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization...GALT stock rating and analysis - Galectin Therapeutics Inc : a summary of key financial strength and profitability metrics. Get Your 7-Day Free Trial! Start Now! Login . Home . Homepage Membership Levels General Discussion Complete Stock List The book Podcast Membership Data Coverage Founder's Message Free TrialAuction Market 12495 East Stockton Blvd. | Galt, CA 95632 Phone: 209-745-1515 | Fax: 209-745-1582 Email: [email protected] latest messages and market ideas from Galectin Therapeutics (@GalectinTherapeutics) on Stocktwits. Galectin Therapeutics Inc. (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins. houses for rent dundasona bola sex hikoyalar Is Galectin Therapeutics Inc. (GALT) A Good Stock To Buy? We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively...Closing yesterday's session at $2.59, the stock is trading 54.6% below its all-time high. Also, the stock has declined 26% over the past month and 6.8% over the past year. GALT is currently ...Company Name: Galectin Therapeutics Inc., Stock Symbol: GALT, Industry: Biotechs, Total Posts: 3747, Last Post: 2/1/2022 3:50:12 PMGALT reported positive results for cancer immunotherapy one week ago. This was followed by algorithm trading taking the stock price lower. There is high open interest on $3, $4, and $5 calls expiring today.Find the latest Galectin Therapeutics Inc. (GALT) stock quote, history, news and other vital information to help you with your stock trading and investing.Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the ...View Galectin Therapeutics Inc GALT investment & stock information. Get the latest Galectin Therapeutics Inc GALT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. 100% Free, Limited Time Only! Free Signup. Should I buy or sell GALT stock? If you are thinking about buying GALT, make sure you check out the free GALT stock predictions report provided by MarketClub. They use their proprietary Smart Scan and Trade Triangle ... Auction Market 12495 East Stockton Blvd. | Galt, CA 95632 Phone: 209-745-1515 | Fax: 209-745-1582 Email: [email protected] Therapeutics Inc. (NASDAQ:GALT) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for GALT is 23.5 ...In depth view into GALT (Galectin Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.A Form 4 filing filed with the SEC on Tuesday, January 19 showed that Amelio Gilbert F sold 60,000 shares of Galectin Therapeutics Inc (NASDAQ: GALT )at an average price of $2.17.Mr. Lewis and Galectin Therapeutics Inc. entered into an employment agreement, dated August 31, 2020, and a Deferred Stock Unit Agreement, dated August 31, 2020. Pursuant to these agreements, 80% of Mr. Lewis' compensation will be paid in the form of deferred stock units ("DSUs") in accordance with the terms and subject to the provisions set ...Galectin's lead drug, belapectin (GR‑MD‑02), is a carbohydrate-based drug that inhibits the galectin‑3 protein, involved in many inflammatory, fibrotic, and malignant diseases. Learn More Corporate Snapshot Latest Corporate Presentation View Now Media Fact Sheet View Now GALT (Common Stock) Exchange NASDAQ Price $1.54 Change (%) -0.14 (-8.33%)Providing all your landscaping needs. of concrete, decorative rocks, stone, barks & soils. for Galt and surrounding areas. We stock a large variety of decorative landscape. materials for your next outdoor fountain, patio, walkway, driveway, entryway, outdoor steps, retaining wall, or pond. Come to us, for all your landscaping materials:Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-Industry N/A Sector Medical Current Symbol NASDAQ:GALT Previous Symbol CUSIP N/A CIK 1133416 Web www.galectintherapeutics.com Phone (678) 620-3186 Fax 770-864-1327 Employees 6 Year Founded N/A Sales & Book Value Annual Sales N/A Price / Sales N/A Cash Flow N/A Price / Cash Flow N/AShares of GALT stock opened at $1.58 on Wednesday. The stock's 50-day simple moving average is $1.71 and its 200-day simple moving average is $2.18. The company has a debt-to-equity ratio of 79 ...norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... wrong synonym Galectin Therapeutics Inc (NAS:GALT) $ 1.55 0.02 (1.31%) Market Cap: 92.00 Mil Enterprise Value: 83.66 Mil PE Ratio: 0 PB Ratio: 258.33 Summary 30-Y Financials Stock Report Guru Trades Analysis DCF Interactive Chart Dividend Insider Ownership Data Operating Headlines Checklist Baskets Definitions Learn how to easily invest in Galectin Therapeutics stock. Galectin Therapeutics Inc. NASDAQ: GALT -USD. $1.74 - $0.03 ( - 1.69%) BIOTECHNOLOGY. Buy Galectin Therapeutics Stocks Updated Aug 4, 2021. Fact checked. Galectin Therapeutics Inc is a biotechnology business based in the US. ...Shares of GALT stock opened at $1.58 on Wednesday. The stock's 50-day simple moving average is $1.71 and its 200-day simple moving average is $2.18. The company has a debt-to-equity ratio of 79 ...A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... Corporate financial information, including the financial reports and SEC filings for Galectin Therapeutics (NASDAQ:GALT)Analyst Price Target on GALT. Based on 1 Wall Street analysts offering 12 month price targets for Galectin Therapeutics in the last 3 months. The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00. The average price target represents a 803.23% change from the last price of $1.55.Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-Industry N/A Sector Medical Current Symbol NASDAQ:GALT Previous Symbol CUSIP N/A CIK 1133416 Web www.galectintherapeutics.com Phone (678) 620-3186 Fax 770-864-1327 Employees 6 Year Founded N/A Sales & Book Value Annual Sales N/A Price / Sales N/A Cash Flow N/A Price / Cash Flow N/AInvestors need to pay close attention to Galectin Therapeutics (GALT) stock based on the movements in the options market lately. GALT : 1.9600 (-1.01%) Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020 GlobeNewswire - Tue Sep 22, 7:04AM CDTGALT updated stock price target summary. Dow Jones, a News Corp company About WSJ. News Corp is a global, diversified media and information services company focused on creating and distributing ...May 02, 2022 · Galectin Therapeutics' stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GALT stock has decreased by 21.1% and is now trading at $1.57. View which stocks have been most impacted by COVID-19. GALT updated stock price target summary. Dow Jones, a News Corp company About WSJ. News Corp is a global, diversified media and information services company focused on creating and distributing ...To access the latest ESG Research, Visit the new Stock Dashboard Full Time Employees: 9 Executives galectintherapeutics.com 4960 Peachtree Industrial Boulevard, Suite 240 Norcross, GA 30071 United States of America 1-678 620 3186 Analyst Opinions Equity Summary Score -active tab All OpinionsA stock character is a stereotypical fictional person or type of person in a work of art such as a novel, play, or a film whom audiences recognize from frequent recurrences in a particular literary tradition. There is a wide range of stock characters, covering men and women of various ages, social classes and demeanors. The current stock price for Galectin Therapeutics (NASDAQ: GALT), and a historical stock chart of stock price and share volume.GALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization... craiglist topeka Analysts like Galectin Therapeutics stock more than the stock of other Medical companies. The consensus rating score for Galectin Therapeutics is 3.00 while the average consensus rating score for medical companies is 2.73. Do MarketBeat users like Galectin Therapeutics more than its competitors?Galectin Therapeutics Inc. is a biotechnology company that is focused on developing novel therapies to improve the lives of patients with chronic liver disease and cancer. The Company's product candidates include galectin-3 inhibitor, belapectin (GR-MD-02) and GM-CT-01.norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... Historical daily share price chart and data for Galectin Therapeutics since 2022 adjusted for splits. The latest closing stock price for Galectin Therapeutics as of April 19, 2022 is 1.70.. The all-time high Galectin Therapeutics stock closing price was 36.83 on September 11, 2003.; The Galectin Therapeutics 52-week high stock price is 5.70, which is 235.3% above the current share price.Galectin Therapeutics Inc. advanced stock charts by MarketWatch. View GALT historial stock data and compare to other stocks and exchanges.Analyst Forecast. According to 7 analysts, the average rating for GALT stock is "Buy." The 12-month stock price forecast is 14.28, which is an increase of 740.00% from the latest price.Galectin Therapeutics seeks to broaden the scope of galectin-related disease indications and science. Therefore, we have established a number of academic collaborations with investigators and welcome opportunities to work with additional investigators. Click here to contact us.Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Analyst Price Target on GALT. Based on 1 Wall Street analysts offering 12 month price targets for Galectin Therapeutics in the last 3 months. The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00. The average price target represents a 803.23% change from the last price of $1.55.You can buy Galectin Therapeutics Inc (GALT) stock and many other stocks or ETFs on Stash. Purchase fractional shares with any dollar amount. GALT is presenting 6 scientific abstracts at AASLD, the world's premier meeting on liver disease. BULLISH 🐂. Presentation Details. Title: Mechanism of galectin-3 binding by belapectin, a galectin-3 inhibitor developed for NASH cirrhosis Galectin-3, a glycan binding protein, plays a central role to foster liver inflammation and fibrosis in ...Apr 27, 2022 · A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Stock Picks. Today's 52-Week Highs; Today's 52-Week Lows; Volume Shockers; Price Shockers; High-yield Stocks; The Best Blue-Chip Stocks; AdChoices. GALECTIN THERAPEUTICS INC. NASDAQ: GALT. US ...Galt Singles Clubs, Best Free Hookup Sites Barberton Ohio, Hookup Maywood, Black Dating Sites Near Pasadena, Casual Hookup Fleming Island Fl, Local Singles In Nashua Nh, Asian Dating Near Jupiter Fl May 02, 2022 · Galectin Therapeutics' stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GALT stock has decreased by 21.1% and is now trading at $1.57. View which stocks have been most impacted by COVID-19. GALT reported positive results for cancer immunotherapy one week ago. This was followed by algorithm trading taking the stock price lower. There is high open interest on $3, $4, and $5 calls expiring today.norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... Analysts like Galectin Therapeutics stock more than the stock of other Medical companies. The consensus rating score for Galectin Therapeutics is 3.00 while the average consensus rating score for medical companies is 2.73. Do MarketBeat users like Galectin Therapeutics more than its competitors?Auction Market 12495 East Stockton Blvd. | Galt, CA 95632 Phone: 209-745-1515 | Fax: 209-745-1582 Email: [email protected] dream net worthpictures of boobies Galectin Therapeutics Inc (NAS:GALT) $ 1.55 0.02 (1.31%) Market Cap: 92.00 Mil Enterprise Value: 83.66 Mil PE Ratio: 0 PB Ratio: 258.33 Summary 30-Y Financials Stock Report Guru Trades Analysis DCF Interactive Chart Dividend Insider Ownership Data Operating Headlines Checklist Baskets Definitions GALT Stock Trend. The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.55% during the next 3 months and, with a 90% probability hold a price between $1.06 and $1.23 at the end of this 3-month period.Analyst Price Target on GALT. Based on 1 Wall Street analysts offering 12 month price targets for Galectin Therapeutics in the last 3 months. The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00. The average price target represents a 803.23% change from the last price of $1.55.To access the latest ESG Research, Visit the new Stock Dashboard Full Time Employees: 9 Executives galectintherapeutics.com 4960 Peachtree Industrial Boulevard, Suite 240 Norcross, GA 30071 United States of America 1-678 620 3186 Analyst Opinions Equity Summary Score -active tab All OpinionsGet the latest Galectin Therapeutics Inc. Common Stock (GALT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... View the latest GALT stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of GALECTIN THERAPEUTICS INC.Providing all your landscaping needs. of concrete, decorative rocks, stone, barks & soils. for Galt and surrounding areas. We stock a large variety of decorative landscape. materials for your next outdoor fountain, patio, walkway, driveway, entryway, outdoor steps, retaining wall, or pond. Come to us, for all your landscaping materials:Analyst Forecast. According to 7 analysts, the average rating for GALT stock is "Buy." The 12-month stock price forecast is 14.28, which is an increase of 740.00% from the latest price.Providing all your landscaping needs. of concrete, decorative rocks, stone, barks & soils. for Galt and surrounding areas. We stock a large variety of decorative landscape. materials for your next outdoor fountain, patio, walkway, driveway, entryway, outdoor steps, retaining wall, or pond. Come to us, for all your landscaping materials:GALT, $GALT, Galectin Therapeutics Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicatorsGalectin Therapeutics Inc. is a biotechnology company that is focused on developing therapies to improve the lives of patients with fibrotic disease, chronic liver disease and cancer. The Company’s product candidates include galectin-3 inhibitor, which is a belapectin (GR-MD-02) and GM-CT-01. The Company’s lead drug belapectin is ...May 27, 2021 · Serena Williams is bidding for a record-equalling 24th career major title, although she already holds the record for the Open Era. She has been drawn in the same quarter as Aryna Sabalenka, with Petra Kvitova, Andgelique Kerber, and Madison Keys also potential opponents. Browse 84 professional galt ontario stock photos available royalty-free. Street Scene in Downtown Galt, Ontario, Canada. The community is part of the city of Cambridge, Ontario, Canada which, in turn, is included in the larger. View From The Top Of Dickson Street In Galt, Ontario.Apr 29, 2022 · Galectin Therapeutics Inc NASDAQ Updated Apr 29, 2022 8:00 PM. GALT 1.55 0.02 (1.31%). Post-Market 0.00 (0.00%) View Galectin Therapeutics Inc GALT investment & stock information. Get the latest Galectin Therapeutics Inc GALT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Find real-time GALT - Galectin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.At a current price of around $3.50 per share, Galectin is right in the middle of the range. Accordingly, momentum traders may consider this stock on today's buying pressure, amid surging interest...A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.GALT : 1.5700 (+1.29%) Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein Globe Newswire - Tue Dec 21, 2021. NORCROSS, Ga., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin... mazishi ya rose muhandonurture right 360 Company Name: Galectin Therapeutics Inc., Stock Symbol: GALT, Industry: Biotechs, Total Posts: 3747, Last Post: 2/1/2022 3:50:12 PMApr 18, 2022 · GALT | Complete Galectin Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Learn how to easily invest in Galectin Therapeutics stock. Galectin Therapeutics Inc. NASDAQ: GALT -USD. $1.74 - $0.03 ( - 1.69%) BIOTECHNOLOGY. Buy Galectin Therapeutics Stocks Updated Aug 4, 2021. Fact checked. Galectin Therapeutics Inc is a biotechnology business based in the US. ...Analyst Price Target on GALT. Based on 1 Wall Street analysts offering 12 month price targets for Galectin Therapeutics in the last 3 months. The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00. The average price target represents a 803.23% change from the last price of $1.55.Learn how to easily invest in Galectin Therapeutics stock. Galectin Therapeutics Inc. NASDAQ: GALT -USD. $1.74 - $0.03 ( - 1.69%) BIOTECHNOLOGY. Buy Galectin Therapeutics Stocks Updated Aug 4, 2021. Fact checked. Galectin Therapeutics Inc is a biotechnology business based in the US. ...GALT stock rating and analysis - Galectin Therapeutics Inc : a summary of key financial strength and profitability metrics. Get Your 7-Day Free Trial! Start Now! Login . Home . Homepage Membership Levels General Discussion Complete Stock List The book Podcast Membership Data Coverage Founder's Message Free TrialGALECTIN THERAPEUTICS stock was originally listed at a price of $12.00 in Sep 9, 2002. If you had invested in GALECTIN THERAPEUTICS stock at $12.00, your return over the last 19 years would have been -86%, for an annualized return of -9.83% (not including any dividends or dividend reinvestments).At a current price of around $3.50 per share, Galectin is right in the middle of the range. Accordingly, momentum traders may consider this stock on today's buying pressure, amid surging interest...GALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization... Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the ...Galectin Therapeutics Inc.'s (NASDAQ:GALT) value has fallen 11% in the last week, but insiders who sold US$130k worth of stock over the last year have had less success. Insiders might have been... iyami meaningvintage accent chairs with arms At a current price of around $3.50 per share, Galectin is right in the middle of the range. Accordingly, momentum traders may consider this stock on today's buying pressure, amid surging interest...Galectin Therapeutics Inc (NAS:GALT) $ 1.55 0.02 (1.31%) Market Cap: 92.00 Mil Enterprise Value: 83.66 Mil PE Ratio: 0 PB Ratio: 258.33 Summary 30-Y Financials Stock Report Guru Trades Analysis DCF Interactive Chart Dividend Insider Ownership Data Operating Headlines Checklist Baskets Definitions A stock character is a stereotypical fictional person or type of person in a work of art such as a novel, play, or a film whom audiences recognize from frequent recurrences in a particular literary tradition. There is a wide range of stock characters, covering men and women of various ages, social classes and demeanors. Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-Industry N/A Sector Medical Current Symbol NASDAQ:GALT Previous Symbol CUSIP N/A CIK 1133416 Web www.galectintherapeutics.com Phone (678) 620-3186 Fax 770-864-1327 Employees 6 Year Founded N/A Sales & Book Value Annual Sales N/A Price / Sales N/A Cash Flow N/A Price / Cash Flow N/ASEC Filings. Analyst Coverage. Corporate Governance. Shareholder Services. Corporate Presentation. Contact. Developing novel therapeutics. for metabolic and endocrine disorders. Developing novel therapeutics. Find the latest Galectin Therapeutics Inc., GALT stock market data. Get a full understanding of how Galectin Therapeutics Inc. is performing with stock quotes and prices, as well as real-time news ...A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Closing yesterday's session at $2.59, the stock is trading 54.6% below its all-time high. Also, the stock has declined 26% over the past month and 6.8% over the past year. GALT is currently ...Galectin Therapeutics Inc. GALT stock price today per share is 1.7 USD. How to purchase Galectin Therapeutics Inc. stock? You can buy GALT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker. What is the ticker symbol for Galectin Therapeutics Inc.? The stock symbol or ticker of Galectin Therapeutics Inc. is GALT.norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... A.L.I. is an ISO 9001-certified label manufacturer specializing in product and packaging labels for many industries, especially the automotive OEM and after market parts industries. We have the capacity to print up to seven colors, including 4-color process, and employ a full service Art & Design Department utilizing state-of-the-art computers ... The Galectin Therapeutics Inc. stock price fell by -1.19% on the last day (Friday, 22nd Apr 2022) from $1.68 to $1.66. and has now fallen 3 days in a row. During the day the stock fluctuated 6.17% from a day low at $1.62 to a day high of $1.72.Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share Simply Wall St • Nov 17, 2021 How Much Of Galectin...Galectin Therapeutics Inc. (NASDAQ:GALT) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for GALT is 23.5 ...Galectin Therapeutics Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Streamlining Its Capital Structure GlobeNewswire Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases.Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share Simply Wall St • Nov 17, 2021 How Much Of Galectin...Galectin Therapeutics Inc - GALT stock news. Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public. gats iogasolinera cerca de mi ubicacion Find real-time GALT - Galectin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.GALECTIN THERAPEUTICS stock was originally listed at a price of $12.00 in Sep 9, 2002. If you had invested in GALECTIN THERAPEUTICS stock at $12.00, your return over the last 19 years would have been -86%, for an annualized return of -9.83% (not including any dividends or dividend reinvestments).Galectin Therapeutics Inc.'s (NASDAQ:GALT) value has fallen 11% in the last week, but insiders who sold US$130k worth of stock over the last year have had less success. Insiders might have been...GALT, $GALT, Galectin Therapeutics Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicatorsInvestors need to pay close attention to Galectin Therapeutics (GALT) stock based on the movements in the options market lately. GALT : 1.9600 (-1.01%) Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020 GlobeNewswire - Tue Sep 22, 7:04AM CDTTo access the latest ESG Research, Visit the new Stock Dashboard Full Time Employees: 9 Executives galectintherapeutics.com 4960 Peachtree Industrial Boulevard, Suite 240 Norcross, GA 30071 United States of America 1-678 620 3186 Analyst Opinions Equity Summary Score -active tab All OpinionsGALT stock rating and analysis - Galectin Therapeutics Inc : a summary of key financial strength and profitability metrics. Get Your 7-Day Free Trial! Start Now! Login . Home . Homepage Membership Levels General Discussion Complete Stock List The book Podcast Membership Data Coverage Founder's Message Free TrialTicker: GALT. Galectin Therapeutics Inc is a incorporated in the state of Nevada. Galectin Therapeutics Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current ...GALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization...Find real-time GALT - Galectin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.GALT stock rating and analysis - Galectin Therapeutics Inc : a summary of key financial strength and profitability metrics. Get Your 7-Day Free Trial! Start Now! Login . Home . Homepage Membership Levels General Discussion Complete Stock List The book Podcast Membership Data Coverage Founder's Message Free TrialThe Galectin Therapeutics Inc. stock price fell by -1.19% on the last day (Friday, 22nd Apr 2022) from $1.68 to $1.66. and has now fallen 3 days in a row. During the day the stock fluctuated 6.17% from a day low at $1.62 to a day high of $1.72.May 02, 2022 · Galectin Therapeutics' stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GALT stock has decreased by 21.1% and is now trading at $1.57. View which stocks have been most impacted by COVID-19. A.L.I. is an ISO 9001-certified label manufacturer specializing in product and packaging labels for many industries, especially the automotive OEM and after market parts industries. We have the capacity to print up to seven colors, including 4-color process, and employ a full service Art & Design Department utilizing state-of-the-art computers ... To see how Galectin Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: GALT stock's performance was 10.13% in the latest trading, and -20.55% in the past year, while Savara Inc. (SVRA) has traded -2.33% on the day and positioned -28.00% lower than it was a year ago.GALT : 1.5700 (+1.29%) Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein Globe Newswire - Tue Dec 21, 2021. NORCROSS, Ga., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...At a current price of around $3.50 per share, Galectin is right in the middle of the range. Accordingly, momentum traders may consider this stock on today's buying pressure, amid surging interest...You can buy Galectin Therapeutics Inc (GALT) stock and many other stocks or ETFs on Stash. Purchase fractional shares with any dollar amount. Stock Picks. Today's 52-Week Highs; Today's 52-Week Lows; Volume Shockers; Price Shockers; High-yield Stocks; The Best Blue-Chip Stocks; AdChoices. GALECTIN THERAPEUTICS INC. NASDAQ: GALT. US ...Mr. Lewis and Galectin Therapeutics Inc. entered into an employment agreement, dated August 31, 2020, and a Deferred Stock Unit Agreement, dated August 31, 2020. Pursuant to these agreements, 80% of Mr. Lewis' compensation will be paid in the form of deferred stock units ("DSUs") in accordance with the terms and subject to the provisions set ...A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Apr 27, 2022 · A high-level overview of Galectin Therapeutics Inc. (GALT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A stock character is a stereotypical fictional person or type of person in a work of art such as a novel, play, or a film whom audiences recognize from frequent recurrences in a particular literary tradition. There is a wide range of stock characters, covering men and women of various ages, social classes and demeanors. GALT : 1.5700 (+1.29%) Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein Globe Newswire - Tue Dec 21, 2021. NORCROSS, Ga., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...Apr 29, 2022 · Galectin Therapeutics Inc NASDAQ Updated Apr 29, 2022 8:00 PM. GALT 1.55 0.02 (1.31%). Post-Market 0.00 (0.00%) GALECTIN THERAPEUTICS stock was originally listed at a price of $12.00 in Sep 9, 2002. If you had invested in GALECTIN THERAPEUTICS stock at $12.00, your return over the last 19 years would have been -86%, for an annualized return of -9.83% (not including any dividends or dividend reinvestments).To see how Galectin Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: GALT stock's performance was 10.13% in the latest trading, and -20.55% in the past year, while Savara Inc. (SVRA) has traded -2.33% on the day and positioned -28.00% lower than it was a year ago. kiko milanoea payslips Galt International. 8833 Flower Rd Rancho Cucamonga, CA 91730. Need Help? Call: (909) 483-5859 [email protected] SUPPORT. About Us Search Products ... At a current price of around $3.50 per share, Galectin is right in the middle of the range. Accordingly, momentum traders may consider this stock on today's buying pressure, amid surging interest...Learn how to easily invest in Galectin Therapeutics stock. Galectin Therapeutics Inc. NASDAQ: GALT -USD. $1.74 - $0.03 ( - 1.69%) BIOTECHNOLOGY. Buy Galectin Therapeutics Stocks Updated Aug 4, 2021. Fact checked. Galectin Therapeutics Inc is a biotechnology business based in the US. ...May 27, 2021 · Serena Williams is bidding for a record-equalling 24th career major title, although she already holds the record for the Open Era. She has been drawn in the same quarter as Aryna Sabalenka, with Petra Kvitova, Andgelique Kerber, and Madison Keys also potential opponents. May 27, 2021 · Serena Williams is bidding for a record-equalling 24th career major title, although she already holds the record for the Open Era. She has been drawn in the same quarter as Aryna Sabalenka, with Petra Kvitova, Andgelique Kerber, and Madison Keys also potential opponents. Galectin Therapeutics seeks to broaden the scope of galectin-related disease indications and science. Therefore, we have established a number of academic collaborations with investigators and welcome opportunities to work with additional investigators. Click here to contact us.Analyst Price Target on GALT. Based on 1 Wall Street analysts offering 12 month price targets for Galectin Therapeutics in the last 3 months. The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00. The average price target represents a 803.23% change from the last price of $1.55.GALT : 1.5700 (+1.29%) Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein Globe Newswire - Tue Dec 21, 2021. NORCROSS, Ga., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...Peter G. Traber. Employees: 7. 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA 30071. 678-620-3186. www.galectintherapeutics.com. Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Galectin Therapeutics Inc. GALT stock price today per share is 1.7 USD. How to purchase Galectin Therapeutics Inc. stock? You can buy GALT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker. What is the ticker symbol for Galectin Therapeutics Inc.? The stock symbol or ticker of Galectin Therapeutics Inc. is GALT.In depth view into GALT (Galectin Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.Company Name: Galectin Therapeutics Inc., Stock Symbol: GALT, Industry: Biotechs, Total Posts: 3747, Last Post: 2/1/2022 3:50:12 PMCorporate financial information, including the financial reports and SEC filings for Galectin Therapeutics (NASDAQ:GALT)Apr 29, 2022 · Galectin Therapeutics Inc NASDAQ Updated Apr 29, 2022 8:00 PM. GALT 1.55 0.02 (1.31%). Post-Market 0.00 (0.00%) Find the latest Gilat Satellite Networks Ltd. (GILT) stock quote, history, news and other vital information to help you with your stock trading and investing.Galectin Therapeutics Inc Forecast, Short-Term " GALT" Stock Price Prognosis for Next Days Walletinvestor.com GALT Forecast, Long-Term Price Predictions for Next Months and Year: 2021, 2022Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share Simply Wall St • Nov 17, 2021 How Much Of Galectin...GALT : Galectin Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical AnalysisMay 02, 2022 · Galectin Therapeutics' stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GALT stock has decreased by 21.1% and is now trading at $1.57. View which stocks have been most impacted by COVID-19. Galectin Therapeutics seeks to broaden the scope of galectin-related disease indications and science. Therefore, we have established a number of academic collaborations with investigators and welcome opportunities to work with additional investigators. Click here to contact us.Company Name: Galectin Therapeutics Inc., Stock Symbol: GALT, Industry: Biotechs, Total Posts: 3747, Last Post: 2/1/2022 3:50:12 PMGALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization... Shares of GALT stock opened at $1.58 on Wednesday. The stock's 50-day simple moving average is $1.71 and its 200-day simple moving average is $2.18. The company has a debt-to-equity ratio of 79 ...The current stock price for Galectin Therapeutics (NASDAQ: GALT), and a historical stock chart of stock price and share volume.Browse 84 professional galt ontario stock photos available royalty-free. Street Scene in Downtown Galt, Ontario, Canada. The community is part of the city of Cambridge, Ontario, Canada which, in turn, is included in the larger. View From The Top Of Dickson Street In Galt, Ontario.Closing yesterday's session at $2.59, the stock is trading 54.6% below its all-time high. Also, the stock has declined 26% over the past month and 6.8% over the past year. GALT is currently ...Investors need to pay close attention to Galectin Therapeutics (GALT) stock based on the movements in the options market lately. GALT : 1.9600 (-1.01%) Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020 GlobeNewswire - Tue Sep 22, 7:04AM CDTGALT Galectin Therapeutics Inc Current Report Filing (8-k) On March 31, 2022, Galectin Therapeutics Inc. ("Galectin Therapeutics") issued a press release announcing its results of operations and financial condition as of and for the year ended December 31, 2021 and provided a business update.Apr 29, 2022 · Galectin Therapeutics Inc NASDAQ Updated Apr 29, 2022 8:00 PM. GALT 1.55 0.02 (1.31%). Post-Market 0.00 (0.00%) To access the latest ESG Research, Visit the new Stock Dashboard Full Time Employees: 9 Executives galectintherapeutics.com 4960 Peachtree Industrial Boulevard, Suite 240 Norcross, GA 30071 United States of America 1-678 620 3186 Analyst Opinions Equity Summary Score -active tab All OpinionsThe latest messages and market ideas from Galectin Therapeutics (@GalectinTherapeutics) on Stocktwits. Galectin Therapeutics Inc. (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.Analysts like Galectin Therapeutics stock more than the stock of other Medical companies. The consensus rating score for Galectin Therapeutics is 3.00 while the average consensus rating score for medical companies is 2.73. Do MarketBeat users like Galectin Therapeutics more than its competitors?To see how Galectin Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: GALT stock's performance was 10.13% in the latest trading, and -20.55% in the past year, while Savara Inc. (SVRA) has traded -2.33% on the day and positioned -28.00% lower than it was a year ago.Galectin Therapeutics Inc Forecast, Short-Term " GALT" Stock Price Prognosis for Next Days Walletinvestor.com GALT Forecast, Long-Term Price Predictions for Next Months and Year: 2021, 2022GALT, $GALT, Galectin Therapeutics Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicatorsnorcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... GALT Galectin Therapeutics Inc Current Report Filing (8-k) On March 31, 2022, Galectin Therapeutics Inc. ("Galectin Therapeutics") issued a press release announcing its results of operations and financial condition as of and for the year ended December 31, 2021 and provided a business update.Galectin Therapeutics Inc insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information.Corporate financial information, including the financial reports and SEC filings for Galectin Therapeutics (NASDAQ:GALT)The latest messages and market ideas from Galectin Therapeutics (@GalectinTherapeutics) on Stocktwits. Galectin Therapeutics Inc. (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.GALT Stock Trend. The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.55% during the next 3 months and, with a 90% probability hold a price between $1.06 and $1.23 at the end of this 3-month period.Browse 84 professional galt ontario stock photos available royalty-free. Street Scene in Downtown Galt, Ontario, Canada. The community is part of the city of Cambridge, Ontario, Canada which, in turn, is included in the larger. View From The Top Of Dickson Street In Galt, Ontario.GALT updated stock price target summary. Dow Jones, a News Corp company About WSJ. News Corp is a global, diversified media and information services company focused on creating and distributing ...Find the latest Galectin Therapeutics Inc., GALT stock market data. Get a full understanding of how Galectin Therapeutics Inc. is performing with stock quotes and prices, as well as real-time news ...GALT Stock Price Chart Interactive Chart > GALT Price/Volume Stats. Current price $1.68 : 52-week high $5.70 : Prev. close $1.74 : 52-week low $1.50 : Day low $1.66 : Volume 158,400 : Day high ...GALT $1.74 $0.16 10.1% Price as of April 14, 2022, 4:00 p.m. ET View Interactive GALT Charts A development stage pharmaceutical company engaged in the discovery, development and commercialization...GALT updated stock price target summary. Dow Jones, a News Corp company About WSJ. News Corp is a global, diversified media and information services company focused on creating and distributing ...Galectin Therapeutics Inc NASDAQ Updated Apr 29, 2022 8:00 PM. GALT 1.55 0.02 (1.31%). Post-Market 0.00 (0.00%)Ticker: GALT. Galectin Therapeutics Inc is a incorporated in the state of Nevada. Galectin Therapeutics Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current ...Implied Volatility Surging for Galectin Therapeutics (GALT) Stock Options 09/29/20-7:52AM EST Zacks New Strong Sell Stocks for August 31st 08/31/20-10:10AM EST ZacksGalectin Therapeutics Inc (NAS:GALT) $ 1.55 0.02 (1.31%) Market Cap: 92.00 Mil Enterprise Value: 83.66 Mil PE Ratio: 0 PB Ratio: 258.33 Summary 30-Y Financials Stock Report Guru Trades Analysis DCF Interactive Chart Dividend Insider Ownership Data Operating Headlines Checklist Baskets Definitions norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... To see how Galectin Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: GALT stock's performance was 10.13% in the latest trading, and -20.55% in the past year, while Savara Inc. (SVRA) has traded -2.33% on the day and positioned -28.00% lower than it was a year ago.Galectin Therapeutics Inc. is a biotechnology company that is focused on developing therapies to improve the lives of patients with fibrotic disease, chronic liver disease and cancer. The Company’s product candidates include galectin-3 inhibitor, which is a belapectin (GR-MD-02) and GM-CT-01. The Company’s lead drug belapectin is ...Peter G. Traber. Employees: 7. 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA 30071. 678-620-3186. www.galectintherapeutics.com. Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. GALT reported positive results for cancer immunotherapy one week ago. This was followed by algorithm trading taking the stock price lower. There is high open interest on $3, $4, and $5 calls expiring today.norcross, ga., dec. 21, 2021 (globe newswire) -- galectin therapeutics inc. (nasdaq:galt), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on... GALT reported positive results for cancer immunotherapy one week ago. This was followed by algorithm trading taking the stock price lower. There is high open interest on $3, $4, and $5 calls expiring today.Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-Industry N/A Sector Medical Current Symbol NASDAQ:GALT Previous Symbol CUSIP N/A CIK 1133416 Web www.galectintherapeutics.com Phone (678) 620-3186 Fax 770-864-1327 Employees 6 Year Founded N/A Sales & Book Value Annual Sales N/A Price / Sales N/A Cash Flow N/A Price / Cash Flow N/AAuction Market 12495 East Stockton Blvd. | Galt, CA 95632 Phone: 209-745-1515 | Fax: 209-745-1582 Email: [email protected] Therapeutics Inc insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information.The latest messages and market ideas from Galectin Therapeutics (@GalectinTherapeutics) on Stocktwits. Galectin Therapeutics Inc. (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.GALT - Short Interest - Galectin Therapeutics Inc Stock - Short Squeeze, Short Sale Volume, Borrow Rates, Fails-To-Deliver Sign Up for a Forever Free Fintel Account. For a limited time, you can sign up for a Forever Free Fintel account. This membership level allows you access to some great features, including a custom dashboard that updates ...To access the latest ESG Research, Visit the new Stock Dashboard Full Time Employees: 9 Executives galectintherapeutics.com 4960 Peachtree Industrial Boulevard, Suite 240 Norcross, GA 30071 United States of America 1-678 620 3186 Analyst Opinions Equity Summary Score -active tab All OpinionsSEC Filings. Analyst Coverage. Corporate Governance. Shareholder Services. Corporate Presentation. Contact. Developing novel therapeutics. for metabolic and endocrine disorders. Developing novel therapeutics. Galectin Therapeutics Inc (NAS:GALT) $ 1.55 0.02 (1.31%) Market Cap: 92.00 Mil Enterprise Value: 83.66 Mil PE Ratio: 0 PB Ratio: 258.33 Summary 30-Y Financials Stock Report Guru Trades Analysis DCF Interactive Chart Dividend Insider Ownership Data Operating Headlines Checklist Baskets Definitions The current stock price for Galectin Therapeutics (NASDAQ: GALT), and a historical stock chart of stock price and share volume.Galectin Therapeutics (GALT) has 2 splits in our GALT split history database. The first split for GALT took place on September 20, 1999. This was a 2 for 1 split, meaning for each share of GALT owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. christian music youtuberoblox wallpapers--L1